Generated $1.1M in revenue in Q3-FY2021 (quarter end April 30, 2021), up 24% YoY, and up 8.6% QoQ. 98% of revenue came from dried flower sales. Revenue was significantly below our expectations as the company has yet to start generating meaningful revenue from its 2.0 products (edibles and beverages).
To read more about THC BioMed Intl Ltd. click below on downloads
Visit THC BioMed Intl Ltd. page for more research, discussion boards and to like, and share.
